These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 3037886)

  • 21. Converting enzyme inhibition: implications for renal perfusion and function.
    Hollenberg NK
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
    Usalan C; Buyukhatipoglu H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the renin-angiotensin system in blood pressure regulation in normotensive animals and man.
    Corvol P; Michel JB; Evin G; Gardes J; Bensala-Alaoui A; Ménard J
    J Hypertens Suppl; 1984 Dec; 2(2):S25-30. PubMed ID: 6100873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ
    Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
    Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Converting enzyme inhibitors and the interaction between kinins and eicosanoids.
    Schrör K
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S60-8. PubMed ID: 1697363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
    Atlas SA; Case DB; Yu ZY; Laragh JH
    Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
    Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs inhibiting the renin - angiotensin system.
    Antonaccio MJ; Cushman DW
    Fed Proc; 1981 Jun; 40(8):2275-84. PubMed ID: 6263716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S; Aurell M
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of prostaglandins in the antihypertensive effect of the converting enzyme inhibitor, enalapril].
    Espinoza F; Gallego A; Ruiz A; Pérez-Grovas H; Garza Flores J; Morato T; Herrera-Acosta J
    Rev Invest Clin; 1989; 41(4):351-60. PubMed ID: 2561022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical pharmacology of ACE inhibitors].
    Hitzenberger G
    Wien Med Wochenschr; 1990 Jan; 140(1-2):12-8. PubMed ID: 2408245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitors: mechanistic controversies.
    Ujhelyi MR; Ferguson RK; Vlasses PH
    Pharmacotherapy; 1989; 9(6):351-62. PubMed ID: 2559394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of angiotensin I converting enzyme inhibitor (captopril) on blood pressure and bradykinin in patients with excessive aldosterone secretion].
    Haruyama K; Mizuno K; Yamazaki M; Toki T; Yaginuma K; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):437-44. PubMed ID: 6381834
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
    Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
    Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bradykinin and inhibition of angiotensin-converting enzyme in hypertension.
    Azizi M
    N Engl J Med; 1999 Mar; 340(12):967; author reply 968-9. PubMed ID: 10094648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.